DC News Now on MSN
What’s Going Around: Non-invasive prostate cancer treatment
Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...
RICHMOND, Va. — A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and ...
SAN ANTONIO, Texas, September 18, 2025--(BUSINESS WIRE)--NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity ...
Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to ...
A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
PANAMA CITY, Fla. (WJHG/WECP) - Hope Regional Medical Center in Panama City is now using a powerful new diagnostic tool in the fight against Prostate Cancer. Doctors at the center have always used CT ...
Molecular evolution of HRR gene alterations in metastatic prostate cancer: A ctDNA-based study. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does ...
NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback